SOHO 最新状态更新和后续问题 | 2022 年 Hyper - CVAD : 经验教训和新方法。
关键词: ALL Blinatumomab Hyper-CVAD Inotuzumab Update
Mesh : Adult Humans Doxorubicin / therapeutic use Cyclophosphamide / therapeutic use Retrospective Studies Antineoplastic Combined Chemotherapy Protocols / adverse effects Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy Dexamethasone / therapeutic use Vincristine / therapeutic use
来 源: DOI:10.1016/j.clml.2023.01.013